Vancouver, British Columbia--(Newsfile Corp. - May 2, 2024) - PreveCeutical Medical Inc. (CSE: PREV) (OTCQB: PRVCF) (FSE: 18H) (the "Company" or "PreveCeutical") announces that the Company has missed the filing deadline of April 29, 2024 to file the Company's audited annual financial statements and accompanying management's discussion and analysis, with related CEO and CFO certificates, for the financial year ended December 31, 2023 (collectively, the "Annual Filings"), as required under applica
PreveCeutical Medical Inc. (the "Company" or "PreveCeutical") (CSE: PREV) (OTCQB: PRVCF) (FSE: 18H), is pleased to announce that it has started preparations to accelerate completion of its preclinical dual gene therapy program using our developed and in vitro validated Smart-siRNA sequences, which when paired with our proprietary bioresponsive lipid-nanoparticulate delivery systems (US patent no. 11,566,044) effectively target the PTPN1 gene.
Broadcastings Begin Saturday, September 23, 2023, at 3:30 PM ET New to The Street Announces its Five Corporate Interviews, airings on Newsmax and FOX Business Network Shows 512/513: 1). American Rebel Holdings, Inc. (NASDAQ: AREB) ($AREB) 2). Society Pass Incorporated (NASDAQ: SOPA) ($SOPA) 3). PreveCeutical Medical, Inc. (OTCQB: PRVCF) (CSE: PREV) (FSE: 18H) 4). Artist – Hope Tain Oil Painting 5). Sekur Private Data, Ltd. (OTCQX: SWISF) (CSE: SKUR) (FRA: GDT0) ($SWISF) (Sekur®) - https://www.ne